loader
Please Wait
Applying Filters...

Ofichem Header Ofichem Header

X

Technical details about Coleneuramide, learn more about the structure, uses, toxicity, action, side effects and more

Client Email Product
Menu
2D Structure
1. Also known as: Mcc-257, Coleneuramide [usan], G2d52t65lr, 204200-47-5, Coleneuramide (usan), Coleneuramide [usan:inn]
Molecular Formula
C39H68N2O8
Molecular Weight
693.0  g/mol
InChI Key
CHMRTBYTCBDIRG-JQZMMWJVSA-N
FDA UNII
G2D52T65LR

Coleneuramide is under investigation in clinical trial NCT00307749 (Safety and Efficacy of MCC-257 in the Treatment of Diabetic Polyneuropathy).
1 2D Structure

2D Structure

2 Identification
2.1 Computed Descriptors
2.1.1 IUPAC Name
(2R,4S,5R,6R)-5-acetamido-N-[(3R,5S,8R,9S,10S,13R,14S,17R)-10,13-dimethyl-17-[(2R)-6-methylheptan-2-yl]-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-3-yl]-4-hydroxy-2-methoxy-6-[(1R,2R)-1,2,3-trihydroxypropyl]oxane-2-carboxamide
2.1.2 InChI
InChI=1S/C39H68N2O8/c1-22(2)9-8-10-23(3)28-13-14-29-27-12-11-25-19-26(15-17-37(25,5)30(27)16-18-38(28,29)6)41-36(47)39(48-7)20-31(44)33(40-24(4)43)35(49-39)34(46)32(45)21-42/h22-23,25-35,42,44-46H,8-21H2,1-7H3,(H,40,43)(H,41,47)/t23-,25+,26-,27+,28-,29+,30+,31+,32-,33-,34-,35-,37+,38-,39-/m1/s1
2.1.3 InChI Key
CHMRTBYTCBDIRG-JQZMMWJVSA-N
2.1.4 Canonical SMILES
CC(C)CCCC(C)C1CCC2C1(CCC3C2CCC4C3(CCC(C4)NC(=O)C5(CC(C(C(O5)C(C(CO)O)O)NC(=O)C)O)OC)C)C
2.1.5 Isomeric SMILES
C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC[C@@H]4[C@@]3(CC[C@H](C4)NC(=O)[C@]5(C[C@@H]([C@H]([C@@H](O5)[C@@H]([C@@H](CO)O)O)NC(=O)C)O)OC)C)C
2.2 Other Identifiers
2.2.1 UNII
G2D52T65LR
2.3 Synonyms
2.3.1 MeSH Synonyms

1. Mcc-257

2.3.2 Depositor-Supplied Synonyms

1. Mcc-257

2. Coleneuramide [usan]

3. G2d52t65lr

4. 204200-47-5

5. Coleneuramide (usan)

6. Coleneuramide [usan:inn]

7. Unii-g2d52t65lr

8. Coleneuramide [inn]

9. Coleneuramide [who-dd]

10. Schembl4061659

11. Chembl2105634

12. Db14932

13. D09404

14. Q27278653

15. Alpha-neuraminamide, N5-acetyl-n1-((3alpha,5alpha)-cholestan-3-yl)-2-o-methyl-

16. .alpha.-neuraminamide, N(sup 5)-acetyl-n(sup 1)-((3.alpha.,5.alpha.)-cholestan-3-yl)-2-o-methyl-

17. 5-acetamido-n-(5.alpha.-cholestan-3.alpha.-yl)-3,5-dideoxy-2-o-methyl-d-glycero-.alpha.-d-galacto-non-2-ulopyranosonamide

18. 5-acetamido-n-(5alpha-cholestan-3alpha-yl)-3,5-dideoxy-2-o-methyl-d-glycero-alpha-d-galacto-non-2-ulopyranosonamide

2.4 Create Date
2010-07-01
3 Chemical and Physical Properties
Molecular Weight 693.0 g/mol
Molecular Formula C39H68N2O8
XLogP36.6
Hydrogen Bond Donor Count6
Hydrogen Bond Acceptor Count8
Rotatable Bond Count12
Exact Mass692.49756713 g/mol
Monoisotopic Mass692.49756713 g/mol
Topological Polar Surface Area158 Ų
Heavy Atom Count49
Formal Charge0
Complexity1150
Isotope Atom Count0
Defined Atom Stereocenter Count15
Undefined Atom Stereocenter Count0
Defined Bond Stereocenter Count0
Undefined Bond Stereocenter Count0
Covalently Bonded Unit Count1
Post Enquiry
POST ENQUIRY